Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Biogaia Adr Class B BIOGY

Healthcare Biotechnology
Biogaia AB is a Sweden-based healthcare company that is engaged in the development and sell of probiotic products. The Company develops, markets and sells probiotic products with documented health benefits. The products are primarily based on different strains of the lactic acid bacterium Limosilactobacillus reuteri. The Company’s activities are divided into three segments: The Paediatrics... see more

Recent & Breaking News (PINL:BIOGY)

DTS Expands Play-Fi® Ecosystem To Include Top ODM Manufacturer Anam Electronics

PR Newswire January 6, 2015

Researchers Find That Tumor DNA and Cells in the Blood Can Be Used to Diagnose Prostate Cancer and Drug Resistance in Breast Cancer

PR Newswire January 6, 2015

Can a Mother "Inherit" the Risk for Rheumatoid Arthritis from her Child?

PR Newswire January 6, 2015

January Issue of Clinical Chemistry Highlights the Molecular Diagnostics Research That Is Changing the Landscape of Medical Testing

PR Newswire January 6, 2015

New Antimicrobial Technology Makes Healthcare And Consumer Products Resistant To The Growth Of Viruses, Fungi And Odor Causing Bacteria

PR Newswire January 6, 2015

QR Pharma Announces the Appointment of New Chairman and New Board Member

Business Wire January 6, 2015

HelomicsTM to Present at Biotech Showcase 2015 During the JP Morgan Healthcare Conference

Business Wire January 6, 2015

Urology Associates of Central Missouri Joins Missouri Cancer Associates, Gains Access to Vast Resources The US Oncology Network Offers to Affiliated Practices

Business Wire January 6, 2015

23andMe and Genentech to Analyze Genomic Data for Parkinson's Disease

PR Newswire January 6, 2015

Nuvilex to Attend 2015 Gastrointestinal Cancers Symposium in San Francisco, January 15-17, 2015

GlobeNewswire January 6, 2015

Anderson and McDaniel to Receive 2015 Georgia Bio Industry Growth Awards

Business Wire January 6, 2015

Cerulean Announces Publication Describing Synergistic Anti-Tumor Activity of CRLX101 with Avastin in Advanced Metastatic Ovarian Tumor Models

Business Wire January 6, 2015

Ambry Genetics Launches Clinically Valuable New Approach to Cardiovascular Genetic Testing

Business Wire January 6, 2015

med fusion Now a Provider for Blue Cross and Blue Shield of Illinois

Business Wire January 6, 2015

Rexahn Pharmaceuticals Announces Publication of Preclinical Data for RX-3117 Demonstrating Effectiveness Against Gemcitabine Resistant Human Cancer Cells

GlobeNewswire January 6, 2015

Ultragenyx Initiates New Development Program Studying KRN23 for the Treatment of Tumor-Induced Osteomalacia

GlobeNewswire January 6, 2015

Ayla Networks Showcases New Customer Products and Expanding IoT Ecosystem Jan. 6 to Jan. 9 in Las Vegas

Marketwired January 6, 2015

Industry Leaders Announce Open Platform for Virtual Reality Gaming

Marketwired January 6, 2015

StoneCalibre Portfolio Company Anatrace Acquires Life Science Tools and Reagents Provider Microlytic

Marketwired January 6, 2015

Diagnovus Acquired by Aegis Sciences Corporation

Business Wire January 6, 2015